BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 38890279)

  • 1. Immuno-protective vesicle-crosslinked hydrogel for allogenic transplantation.
    Wang Y; Huang R; Lu Y; Liu M; Mo R
    Nat Commun; 2024 Jun; 15(1):5176. PubMed ID: 38890279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pancreatic islets engineered with SA-FasL protein establish robust localized tolerance by inducing regulatory T cells in mice.
    Yolcu ES; Zhao H; Bandura-Morgan L; Lacelle C; Woodward KB; Askenasy N; Shirwan H
    J Immunol; 2011 Dec; 187(11):5901-9. PubMed ID: 22068235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Localized Immunomodulation with PD-L1 Results in Sustained Survival and Function of Allogeneic Islets without Chronic Immunosuppression.
    Batra L; Shrestha P; Zhao H; Woodward KB; Togay A; Tan M; Grimany-Nuno O; Malik MT; Coronel MM; García AJ; Shirwan H; Yolcu ES
    J Immunol; 2020 May; 204(10):2840-2851. PubMed ID: 32253240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blocking the monocyte chemoattractant protein-1/CCR2 chemokine pathway induces permanent survival of islet allografts through a programmed death-1 ligand-1-dependent mechanism.
    Lee I; Wang L; Wells AD; Ye Q; Han R; Dorf ME; Kuziel WA; Rollins BJ; Chen L; Hancock WW
    J Immunol; 2003 Dec; 171(12):6929-35. PubMed ID: 14662900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of NLRC5 regulates cytokine expression in CD4+ T helper lymphocytes and prolongs murine islet and skin allograft survival.
    Zhang X; Xue Z; Li Z; Ren A; Zhu X; Deng R; Ma Y
    Mol Immunol; 2021 Sep; 137():67-74. PubMed ID: 34225136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-TCR mAb induces peripheral tolerance to alloantigens and delays islet allograft rejection in autoimmune diabetic NOD mice.
    Deng R; Khattar M; Xie A; Schroder PM; He X; Chen W; Stepkowski SM
    Transplantation; 2014 Jun; 97(12):1216-24. PubMed ID: 24854475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunomodulation with SA-FasL protein as an effective means of preventing islet allograft rejection in chemically diabetic NOD mice.
    Yolcu ES; Zhao H; Shirwan H
    Transplant Proc; 2013 Jun; 45(5):1889-91. PubMed ID: 23769064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Donor-Specific Regulatory T Cell-Mediated Immune Tolerance in an Intrahepatic Murine Allogeneic Islet Transplantation Model with Short-Term Anti-CD154 mAb Single Treatment.
    Lee SJ; Kim HJ; Byun NR; Park CG
    Cell Transplant; 2020; 29():963689720913876. PubMed ID: 32216448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of islet allograft rejection with engineered myoblasts expressing FasL in mice.
    Lau HT; Yu M; Fontana A; Stoeckert CJ
    Science; 1996 Jul; 273(5271):109-12. PubMed ID: 8658177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alloantigen gene transfer to hepatocytes promotes tolerance to pancreatic islet graft by inducing CD8
    Le Guen V; Judor JP; Boeffard F; Gauttier V; Ferry N; Soulillou JP; Brouard S; Conchon S
    J Hepatol; 2017 Apr; 66(4):765-777. PubMed ID: 27914923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection of islet allografts transplanted together with Fas ligand expressing testicular allografts.
    Takeda Y; Gotoh M; Dono K; Nishihara M; Grochowiecki T; Kimura F; Yoshida T; Ohta Y; Ota H; Ohzato H; Umeshita K; Takeda T; Matsuura N; Sakon M; Kayagaki N; Yagita H; Okumura K; Miyasaka M; Monden M
    Diabetologia; 1998 Mar; 41(3):315-21. PubMed ID: 9541172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Operational immune tolerance towards transplanted allogeneic pancreatic islets in mice and a non-human primate.
    Abdulreda MH; Berman DM; Shishido A; Martin C; Hossameldin M; Tschiggfrie A; Hernandez LF; Hernandez A; Ricordi C; Parel JM; Jankowska-Gan E; Burlingham WJ; Arrieta-Quintero EA; Perez VL; Kenyon NS; Berggren PO
    Diabetologia; 2019 May; 62(5):811-821. PubMed ID: 30701283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of liver transplantation on islet allografts: up-regulation of Fas ligand and apoptosis of T lymphocytes are associated with islet graft tolerance.
    Wang XY; Sun J; Wang C; France M; Sheil AG
    Transplantation; 2001 Jan; 71(1):102-11. PubMed ID: 11211174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of tolerance to cardiac allografts using donor splenocytes engineered to display on their surface an exogenous fas ligand protein.
    Yolcu ES; Gu X; Lacelle C; Zhao H; Bandura-Morgan L; Askenasy N; Shirwan H
    J Immunol; 2008 Jul; 181(2):931-9. PubMed ID: 18606644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of islet engraftment and achievement of long-term islet allograft survival by Toll-like receptor 4 blockade.
    Giovannoni L; Muller YD; Lacotte S; Parnaud G; Borot S; Meier RP; Lavallard V; Bédat B; Toso C; Daubeuf B; Elson G; Shang L; Morel P; Kosco-Vilbois M; Bosco D; Berney T
    Transplantation; 2015 Jan; 99(1):29-35. PubMed ID: 25340601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ex vivo expanded human regulatory T cells can prolong survival of a human islet allograft in a humanized mouse model.
    Wu DC; Hester J; Nadig SN; Zhang W; Trzonkowski P; Gray D; Hughes S; Johnson P; Wood KJ
    Transplantation; 2013 Oct; 96(8):707-16. PubMed ID: 23917725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Killer artificial antigen-presenting cells deplete alloantigen-specific T cells in a murine model of alloskin transplantation.
    Shen C; He Y; Cheng K; Zhang D; Miao S; Zhang A; Meng F; Miao F; Zhang J
    Immunol Lett; 2011 Aug; 138(2):144-55. PubMed ID: 21513739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Local immunomodulation Fas ligand-engineered biomaterials achieves allogeneic islet graft acceptance.
    Headen DM; Woodward KB; Coronel MM; Shrestha P; Weaver JD; Zhao H; Tan M; Hunckler MD; Bowen WS; Johnson CT; Shea L; Yolcu ES; García AJ; Shirwan H
    Nat Mater; 2018 Aug; 17(8):732-739. PubMed ID: 29867165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolongation of corneal allograft survival by CTLA4-FasL in a murine model.
    Shi W; Chen M; Xie L
    Graefes Arch Clin Exp Ophthalmol; 2007 Nov; 245(11):1691-7. PubMed ID: 17541621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting the CXCR4-CXCL12 axis mobilizes autologous hematopoietic stem cells and prolongs islet allograft survival via programmed death ligand 1.
    Fiorina P; Jurewicz M; Vergani A; Petrelli A; Carvello M; D'Addio F; Godwin JG; Law K; Wu E; Tian Z; Thoma G; Kovarik J; La Rosa S; Capella C; Rodig S; Zerwes HG; Sayegh MH; Abdi R
    J Immunol; 2011 Jan; 186(1):121-31. PubMed ID: 21131428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.